ClinicalTrialsFinder

Familial Platelet Disorder With Predisposition to Myeloid Malignancies Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI)75 enrolled1 locationNCT06090669